EP3672949
3-(1-Oxóísóindólín-2-ýl)píperidín-2,6-díón-afleiður og notkun á þeim
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
23.8.2018EP published:
21.12.2022EP application number:
18772885.2
EP translation filed:
13.3.2023Grant published:
15.4.2023EPO information:
European Patent Register
Max expiry date:
22.8.2038Expiry date:
22.8.2024
Title in English:
3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOFLanguage of the patent:
English
Timeline
Today
23.8.2018EP application
21.12.2022EP Publication
13.3.2023Translation submitted
15.4.2023Registration published
22.8.2024Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BECKWITH, Rohan Eric JohnAddress:
Cambridge, Massachusetts 02139, US
Name:
BONAZZI, SimoneAddress:
Cambridge, Massachusetts 02139, US
Name:
CERNIJENKO, ArtiomAddress:
Cambridge, Massachusetts 02139, US
Name:
FAZAL, AleemAddress:
Cambridge, Massachusetts 02139, US
Name:
TICHKULE, Ritesh BhanudasjiAddress:
Cambridge, Massachusetts 02139, US
Name:
VISSER, Michael ScottAddress:
Cambridge, Massachusetts 02139, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762549225 PDate:
23.8.2017Country:
US
Classification
Categories:
C07D 401/14, C07D 413/14, C07D 401/04, C07D 407/14, C07D 409/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 487/08, C07D 495/04, C07D 513/04, A61K 31/454, A61K 31/4545, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 26.7.2023
Expires: 22.8.2024
Payer: Árnason Faktor ehf.